Current treatment strategies for pulmonary arterial hypertension.
about
Ambrisentan, a non-peptide endothelin receptor antagonistBloodstream infections in patients given treatment with intravenous prostanoids.Simvastatin, sildenafil and their combination in monocrotaline induced pulmonary arterial hypertension.The PRAISE study: a prospective, multi-center, randomized, double blinded, placebo-controlled study for the evaluation of iloprost in the early postoperative period after liver transplantation (ISRCTN12622749).Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study.Mediators and modulators of pulmonary arterial hypertension.Potential protective properties of a stable, slow-releasing nitric oxide donor, GEA 3175, in the lung.Emerging therapies for pulmonary arterial hypertension.Treatment of pediatric pulmonary hypertensionInhalation therapy to treat pulmonary arterial hypertension.Treatment for pulmonary arterial hypertension-associated right ventricular dysfunction.Impact of pulmonary hypertension on tricuspid valve function.Influence of PEI as a core modifying agent on PLGA microspheres of PGE₁, a pulmonary selective vasodilator.Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure.Fluid resuscitation of hemorrhagic shock with hemoglobin vesicles in Beagle dogs: pilot study.Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in experimental pulmonary hypertension.Rosuvastatin provides pleiotropic protection against pulmonary hypertension, right ventricular hypertrophy, and coronary endothelial dysfunction in rats.Effect of BAY 41-2272 in the pulmonary hypertension induced by heparin-protamine complex in anaesthetized dogs.Cost-utility and budget impact analysis of drug treatments in pulmonary arterial hypertension associated with congenital heart diseases in Thailand.Hyperoxia affects the regional pulmonary ventilation/perfusion ratio: an electrical impedance tomography study.
P2860
Q28260732-92B25FA7-5083-4645-A7FF-52E3FF76217BQ30228937-269FC704-F848-4F28-B499-FE32178AE1FCQ34512580-B5D2255C-F208-4DA1-A0FC-A63E0B9B2862Q34565325-613AD0C3-0200-4F4A-B3AC-EBCB936BEEE6Q35620058-6D622E0E-1BEE-40A0-A821-FDEA7CCE3A0FQ36477935-27492145-8F84-4F7F-B331-F882ACFD22E4Q36703836-7E1C62AC-2145-4802-B15E-12EF1983C254Q36821361-888B5980-289D-4E2B-B8DD-86881AFCA7D6Q37230469-42320528-9C21-4731-9047-35A343585B77Q38162947-1B134BAF-6237-429F-B94C-94E8E304F29DQ38235602-F069C1D0-3031-4892-A4B7-BD5936E41D37Q39446990-2D777593-203C-4D91-A9AB-D372D390F037Q42775300-9945F019-5705-4769-879B-FF135498C5EAQ43198442-0F1DE536-D02B-4B33-9741-1AA238B78043Q45141156-F44AC600-EA93-4633-A8D8-1CD64636AB59Q46494007-089B49DE-0D94-48BC-8723-316D9C2DD228Q46869160-EDDA88E6-94AB-45EC-9A8A-7663B84B2F8AQ48632087-1992E1C0-6ADC-463C-81B4-501508217CC6Q50279979-728A3F80-8B10-4DDA-8862-82588CF8BE4EQ51728040-1E61C500-59EA-4071-884E-06624FB2C43E
P2860
Current treatment strategies for pulmonary arterial hypertension.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Current treatment strategies for pulmonary arterial hypertension.
@ast
Current treatment strategies for pulmonary arterial hypertension.
@en
type
label
Current treatment strategies for pulmonary arterial hypertension.
@ast
Current treatment strategies for pulmonary arterial hypertension.
@en
prefLabel
Current treatment strategies for pulmonary arterial hypertension.
@ast
Current treatment strategies for pulmonary arterial hypertension.
@en
P2860
P1476
Current treatment strategies for pulmonary arterial hypertension.
@en
P2860
P304
P356
10.1111/J.1365-2796.2005.01542.X
P407
P577
2005-09-01T00:00:00Z